Skip to main content
Have a personal or library account? Click to login
Design and statistical optimization of an effervescent floating drug delivery system of theophylline using response surface methodology Cover

Design and statistical optimization of an effervescent floating drug delivery system of theophylline using response surface methodology

Open Access
|Mar 2016

References

  1. 1. M. V. Srikanth, S. A. Sunil, N. S. Rao, B. J. Ram and K. V. R. Murthy, Statistical design and evaluation of a propranolol HCl gastric floating tablet,(2012) 60–69; DOI:.
  2. 2. A. Nanda, M. Ola, R. Bhaskar, C. K. Sharma and S. Nayak, Formulation and evaluation of an effervescent, gastroretentive drug delivery system,.(2010) 60–71; DOI: 10.4103/0253-7613.77344.
  3. 3. S. Arora, J. Ali, A. Ahuja, R. K. Khar and S. Baboota, Floating drug delivery systems: a review..(2005) E372-90; DOI: 10.1208/pt060347.
  4. 4. V. S. Meka, B. J. Ram, S. A. Sunil, N. S. Rao and K. Ramanamurthy, Gastroretentive drug delivery systems: Novel approaches and its evaluation – a review,(2011) 203–216.
  5. 5. V. S. Meka, H. W. L. Vanitha, S. R. Dharmalingham, R. Sheshala and A. Gorajana, Preparation and in vitro characterization of non-effervescent floating drug delivery system of poorly soluble drug, carvedilol phosphate,.(2014) 485–494. DOI: 10.2478/acph-2014-0038.
  6. 6. B. N. Singh and K. H. Kim, Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention,(2000) 235–259; DOI: 10.1016/S0168-3659(99)00204-7.
  7. 7. A. Chandel, K. Chauhan, B. Parashar, H. Kumar and S. Arora, Floating drug delivery systems: a better approach,.(2012) 110–118; DOI:.
  8. 8. S. Desai and S. Bolton, A floating controlled release drug delivery system: in vitro-in vivo evaluation,.(1993) 1321–1325; DOI: 10.1023/A:1018921830385.
  9. 9. J. Dubeh and N. Verma, Floating Drug Delivery System: A Review,(2013) 2893–2899; DOI: 10.13040/IJPSR.0975-8232.4(8).2893-99.
  10. 10. P. J. Barnes, Theophylline,.(2013) 901–906; DOI: 10.1164/rccm.201302-0388PP.
  11. 11. Theophylline,; access date 15/10/2014.
  12. 12. V. S. Meka and V. R. M. Kolapalli, Formulation of gastroretentive floating drug delivery system using hydrophilic polymers and its in vitro characterization,.(2014) 431–439; DOI:.
  13. 13. V. S. Meka, S. Pillai, S. R. Dharmalingham, R. Sheshala and A. Gorajana, Preparation and in vitro characterization of a non-effervescent floating drug delivery system for poorly soluble drug, glipizide,(2015) 193–204.
  14. 14. Evonik Industries. EUDRAGITL100,; access date 24/11/2015.
  15. 15. A. Becker, F. Katzen and L. Lelpi, Xanthan gum biosynthesis and application: a biochemical/genetic perspective,.(1998) 145–152; DOI: 10.1007/s002530051269.
  16. 16. S. Kumar, R. K. Sahu, S. Sharma and R. Jangde, Design and evaluation of an oral floating matrix tablet of salbutamol sulphate,.(2012) 569–576; DOI:.
  17. 17. B. Y. Choia, H. J. Park, S. J. Hwangb and J. B. Parkc, Preparation of alginate beads for floating drug delivery system: Effects of COgas-forming agents,.(2002) 81–91; DOI: 10.1016/S0378-5173(02)00054-6.
  18. 18. V. S. Meka, N. S. Rao, S. A. Sunil, B. J. Ram and K. V. R. Murthy, Statistical optimization of a novel excipient (CMEC) based gastroretentive floating tablet of propranolol HCl and its in vivo buoyancy characterization in healthy human volunteers,.(2012) 1–12; DOI: 10.1186/1560-8115-20-4.
  19. 19. M. Grassi and G. Grassi, Mathematical modeling and controlled drug delivery: matrix systems,(2005) 97–116; DOI: 10.2174/1567201052772906.
  20. 20. F. Khan, M. S. M. Razzak and M. S. Reza, Preparation and in vitro evaluation of theophylline loaded gastroretentive floating tablets of METHOCEL K4M,.(2008) 65–69; DOI: 10.3329/dujps.v7i1.1220.
  21. 21. C. Narendra, M. S. Srinath and A. Moin, The study on the effect of formulation variables on in vitro floating time and the release properties of floating drug delivery system by a statistical optimization technique,(2008) 17–26; DOI: 10.2298/ciceq0801017n.
  22. 22. K. K. Satish, K. P. Santhosh, K. N. Nishanth and B. P. Bharghav, Formulation and in vitro evaluation of ofloxacin tablets,.(2011) 3007.
  23. 23. R. H. Myers, D. C. Montgomery and C. M. A. Cook,3ed., Wiley, New York 2009, pp. 15–29.
  24. 24. V. S. Meka, N. S. Rao, S. A. Sunil, B. J. Ram and K. V. R. Murthy, Thermal sintering: a novel technique used in the design, optimization and biopharmaceutical evaluation of propranolol HCl gastric floating tablets,(2014) 33–45; DOI: 10.3109/03639045.2012.744416.
  25. 25. United.(2006) p. 1474.
  26. 26. UnitedTablet friability. Chapter 1216. USP30–NF25,.(2007) p. 1735.
  27. 27. M. Yasir, M. Asif, A. Bhattacharya and M. Bajpai, Development and evaluation of gastroretentive drug delivery system for theophylline using psyllium husk,.(2010) 792–799.
  28. 28. C. Rajveer, B. S. Rathinaraj, M. Fareedullah, G. S. Bangale and G. Shinde, Design and evaluation of ketorolac tromethamine sustained release matrix tablets,(2010) 57–71.
DOI: https://doi.org/10.1515/acph-2016-0002 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 35 - 51
Accepted on: Dec 22, 2014
Published on: Mar 7, 2016
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2016 Venkata Srikanth Meka, Chew Ee Li, Ravi Sheshala, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.